Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study, BMC Public Health, vol.18, issue.9, p.704, 2011. ,
DOI : 10.1023/A:1025626202235
URL : https://hal.archives-ouvertes.fr/inserm-00628071
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study, BMC Public Health, vol.18, issue.9, p.704, 2011. ,
DOI : 10.1023/A:1025626202235
URL : https://hal.archives-ouvertes.fr/inserm-00628071
UK. 10 Department of Internal Medicine 11 Medical Department 12 School of Health and Caring Sciences, 9 Wales Heart Research Institute, pp.14-698, 1935. ,
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice ,
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries, European Journal of Cardiovascular Prevention & Rehabilitation, vol.371, issue.1, pp.530-540, 2010. ,
DOI : 10.1097/HJR.0b013e3283383f30
Executive summary: heart disease and stroke statistics?2010 update: a report from the American Heart Association, Circulation, issue.7, pp.121948-954, 2010. ,
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, European Heart Journal, vol.24, issue.11, pp.24987-1003, 2003. ,
DOI : 10.1016/S0195-668X(03)00114-3
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA), BMC Public Health, vol.336, issue.1, p.382, 2010. ,
DOI : 10.1136/bmj.39609.449676.25
URL : https://hal.archives-ouvertes.fr/inserm-00622725
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies, Lancet, issue.9733, pp.3752215-2222, 2010. ,
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus, Annals of Internal Medicine, vol.141, issue.6, pp.141421-431, 2004. ,
DOI : 10.7326/0003-4819-141-6-200409210-00007
Estimates of global mortality attributable to smoking in 2000, The Lancet, vol.362, issue.9387, pp.847-852, 2000. ,
DOI : 10.1016/S0140-6736(03)14338-3
Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States, JAMA, issue.18, pp.2892363-2369, 2003. ,
The global burden of diabetes and its complications: an emerging pandemic, Eur J Cardiovasc Prev Rehabil, vol.17, issue.1, pp.3-8, 2010. ,
Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, The Lancet, vol.373, issue.9667, pp.373929-940, 2009. ,
DOI : 10.1016/S0140-6736(09)60330-5
International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis, JAMA, vol.295, issue.2, pp.180-189, 2006. ,
DOI : 10.1001/jama.295.2.180
Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease, American Heart Journal, vol.156, issue.4, pp.719-727, 2008. ,
DOI : 10.1016/j.ahj.2008.05.020
Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western Europe and the United States, Archives of Internal Medicine, vol.167, issue.2, pp.141-147, 2007. ,
DOI : 10.1001/archinte.167.2.141
Lipid Treatment Assessment Project 2: A Multinational Survey to Evaluate the Proportion of Patients Achieving Low-Density Lipoprotein Cholesterol Goals, Circulation, vol.120, issue.1, pp.28-34, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.108.838466
Global burden of hypertension: analysis of worldwide data, The Lancet, vol.365, issue.9455, pp.365217-223, 2005. ,
DOI : 10.1016/S0140-6736(05)70151-3
Global burden of blood-pressure-related disease, 2001, The Lancet, vol.371, issue.9623, pp.1513-1518, 2001. ,
DOI : 10.1016/S0140-6736(08)60655-8
Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, issue.9493, pp.3661267-1278, 2005. ,
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?, BMJ, vol.308, issue.6925, pp.367-372, 1994. ,
DOI : 10.1136/bmj.308.6925.367
The accuracy of self-reported smoking: A systematic review of the relationship between self-reported and cotinine-assessed smoking status, Nicotine & Tobacco Research, vol.11, issue.1, pp.12-24, 2009. ,
DOI : 10.1093/ntr/ntn010
Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use, The Lancet, vol.370, issue.9604, pp.2044-2053, 2007. ,
DOI : 10.1016/S0140-6736(07)61698-5
IPCRG Consensus statement: Tackling the smoking epidemic ??? practical guidance for primary care, Primary Care Respiratory Journal, vol.17, issue.3, pp.185-193, 2008. ,
DOI : 10.3132/pcrj.2008.00060
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association, Circulation, vol.119, issue.2, pp.351-357, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.108.191305
Evolution of all-causes and cardiovascular mortality in the age-group 75???84 years in Europe during the period 1970???1996. A comparison with worldwide changes, European Heart Journal, vol.23, issue.5, pp.384-398, 2002. ,
DOI : 10.1053/euhj.2001.2839
The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway, European Journal of Cardiovascular Prevention & Rehabilitation, vol.47, issue.4, pp.501-507, 2007. ,
DOI : 10.1097/HJR.0b013e328011490a
Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000, European Heart Journal, vol.27, issue.1, pp.107-113, 1970. ,
DOI : 10.1093/eurheartj/ehi511
High cardiovascular mortality in Russia cannot be explained by the classical risk factors. The Arkhangelsk Study, European Journal of Epidemiology, vol.18, issue.9, pp.871-878, 2000. ,
DOI : 10.1023/A:1025626202235
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study, BMC Public Health, vol.18, issue.9, p.704, 2011. ,
DOI : 10.1023/A:1025626202235
URL : https://hal.archives-ouvertes.fr/inserm-00628071